Mastopexy Market Size was valued at USD 1.2 Billion in 2023. The Global Mastopexy industry is projected to grow from USD 1.3 Billion in 2024 to USD 1.9 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.20% during the forecast period (2024 - 2032).Mastopexy is a plastic surgery mammoplasty procedure for raising the sagging breasts by removing excess skin and tightening the surrounding tissues to reshape and support the new breast contour.
A woman's breasts changes over time and becomes susceptible to ptosis or sagging due to aging, weight fluctuations, breastfeeding and pregnancy. Factors such as growing female geriatric population and increasing demands for aesthetic procedures are the major drivers for the market growth during the forecast period. According to the United Census Bureau, the global-female-geriatric population is estimated to reach 4,139 million by 2030 from 3,601 million as recorded in 2015. Moreover, increasing healthcare expenditures along with the growing demands for outpatient surgeries is boosting the market growth. However, factors such as high cost along with the complications of extrusion, seroma, and scarring associated with surgery are projected to restrain the market growth.
On 9 January 2024, Dr. Dana Coberly, a plastic surgeon based in Tampa and certified by the board, released an article discussing the benefits of breast lifts. According to a report published in December 2011, it can increase cup size, reshape or lift sagging breasts, tighten up skin around one’s body and more.
The American Society of Plastic Surgeons (ASPS) collaborated with The Plastic Surgery Foundation (PSF) to announce October 19th as the eleventh annual Breast Reconstruction Awareness Day on Tuesday, October 11th, 2022. Many women who have mastopexy, mastectomy or lumpectomy do not know about the various breast reconstruction options that exist. Realizing that patients need accurate information upon which to base their choices regarding their care, ACLP and PSF created the Breast Reconstruction Awareness Campaign and BRS Day USA, respectively, calling for awareness and giving patients true facts about breastwork.
CollPlant announced in June 2022 that it had launched a study involving large animals for its regenerative breast implant program printed by 3D bioprinting techniques aimed at addressing worldwide market needs.
GC Aesthetics made headlines in May 2022 with their innovative Nipple Areola Complex (NAC) reconstruction implant. This medical device fulfilled the global clinical requirements of women.
Galderma obtained clearance from the United States Food and Drug Administration for RESTYLANE DEFYNE to augment and correct mild to moderate chin retrusion in adults in February 2022.
An example of this is in May 2021 when GC Aesthetics Incorporated introduced PERLE's brand new generation of breast implants. These smooth implants have proprietary surface technology and gel technology that is industry leading for GCA-based products and improved safety system built up over time giving GCA’s excellent long-term safety record.
Galderma was granted approval for RESTYLANE DEFYNE by the United States Food and Drug Administration (FDA) for augmentation and correction of mild to moderate chin retrusion among adults on February 12th, 2021.
The mastopexy market is segmented on the basis of tissue incision, technique, application, and end user.
On the basis of the tissue incision, the market is segmented into skin, adipose, glandular, and others.
On the basis of the technique, the market is categorised into anchor pattern, inverted-T incisions, lollipop pattern, and others.
On the basis of the application, the market is segmented into sagging breast, augmented breast, and others.
On the basis of end users, the market is segmented into hospitals & clinics, ambulatory surgery centres, and others.
The Americas dominates the mastopexy market owing to increasing adoption of new technologies, and developed healthcare sector. Moreover, rising healthcare expenditure and growing female geriatric population within the region boosts the market growth. Additionally, the presence of the developed economies and major market players within the region fuels the market growth.
Europe is the second largest Mastopexy Market owing to rising per capita healthcare sector and increasing demands for aesthetics. On regional basis, Europe is divided into Western Europe and Eastern Europe. Western Europe leads the regional mastopexy market due to the presence of developed economies like France, Germany, and Italy. On the other hand, Eastern Europe is estimated to be the fastest growing region within Europe.
Asia Pacific region is the fastest growing Mastopexy Market. Increasing awareness for women health, growing healthcare sector, and changing lifestyle are the major drivers for the market growth within the region. Moreover, the presence of the economies like Australia and China, which are marked by increasing number of cosmetic procedures within the Asia Pacific region, fuels the market growth. According to the International Society of Plastic Surgery in 2016, approximately 225,002 cosmetic procedures were performed in Australia.
The Middle East & Africa has the least share in the mastopexy market due to presence of poor economies and stringent government policies, especially in the African region. Majority of the market of the Middle East & Africa is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the presence of the economies like Saudi Arabia, Kuwait and Qatar within the region.
Key players for mastopexy market
Intended Audience
| Report Attribute/Metric | Details |
| Market Size | USD 1.9 Billion |
| CAGR | 6.20 % (2024-2032) |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2021 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Tissue Incision, Technique, Application,End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | ALLERGAN (Ireland), Mentor Worldwide LLC (U.S.), GC Aesthetics (Dublin), LIPOELASTIC (England), Cynosure, Inc. (U.S.), POLYTECH Health & Aesthetics (Germany), Sientra, Inc. (U.S.), and others |
| Key Market Opportunities | Innovations in surgical instruments and techniques, such as the use of laser technology and advanced suturing methods, can improve outcomes and patient satisfaction. |
| Key Market Drivers | Increasing awareness and desire for aesthetic enhancement among individuals, particularly women, is a significant driver. |
Mastopexy Market Highlights:
Frequently Asked Questions (FAQ) :
mastopexy market is projected to grow at a 6.20% CAGR between 2024-2032.
The Americas is projected to command the largest share in the mastopexy market.
Key players profiled in the mastopexy market include Sientra, Inc. (U.S.), POLYTECH Health & Aesthetics (Germany), Cynosure, Inc. (U.S.), LIPOELASTIC (England), GC Aesthetics (Dublin), Mentor Worldwide LLC (U.S.), and ALLERGAN (Ireland).
Demand for aesthetic procedures and increase in outpatient surgeries are the key factors driving the mastopexy market growth.
High cost and complications may limit the mastopexy market growth.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
